Olavis 10 MD Tablet contains Olanzapine 10 mg, an atypical antipsychotic agent primarily indicated for the treatment of schizophrenia and bipolar disorder. Olanzapine exerts its therapeutic effects by modulating the activity of various neurotransmitter receptors in the brain, particularly dopamine D2 and serotonin 5-HT2A receptors, which are implicated in the pathophysiology of psychotic and mood disorders. This medication helps to alleviate symptoms such as hallucinations, delusions, disorganized thinking, and mood swings, thereby improving patient functionality and quality of life. Olavis 10 MD is typically administered once daily, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include weight gain, sedation, dry mouth, and metabolic changes such as increased blood glucose and lipid levels; therefore, regular monitoring of metabolic parameters is recommended during treatment. Caution is advised in patients with a history of cardiovascular disease, diabetes, or hepatic impairment. Olanzapine should be used under close medical supervision, with gradual dose titration to minimize side effects. Abrupt discontinuation is discouraged to prevent withdrawal symptoms or relapse. Olavis 10 MD Tablet is a valuable option in the management of severe psychiatric conditions, contributing to symptom control and functional recovery.